Enzymatic procedure for site-specific pegylation of proteins (Q34674760)

3 August 2017

1 reference

title

Enzymatic procedure for site-specific pegylation of proteins (English)

1 reference

3 August 2017

Haruya Sato

1

1 reference

3 August 2017

language of work or name

English

0 references

publication date

1 June 2002

1 reference

Advanced Drug Delivery Reviews

3 August 2017

published in

1 reference

3 August 2017

volume

54

1 reference

3 August 2017

issue

4

1 reference

3 August 2017

page(s)

487-504

1 reference

Functionalized Poly(ethylene glycols) for Preparation of Biologically Relevant Conjugates

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Site-specific chemical modification with polyethylene glycol of recombinant immunotoxin anti-Tac(Fv)-PE38 (LMB-2) improves antitumor activity and reduces animal toxicity and immunogenicity

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Site-directed pegylation of recombinant interleukin-2 at its glycosylation site

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Site-specific attachment of functionalized poly(ethylene glycol) to the amino terminus of proteins

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

1 reference

7 January 2021

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

1 reference

7 January 2021

Factors that govern the specificity of transglutaminase-catalysed modification of proteins and peptides

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Specificity of guinea pig liver transglutaminase for amine substrates

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Selective modification by transglutaminase of a glutamine side chain in the hinge region of the histidine-388→glutamine mutant of yeast phosphoglycerate kinase

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Selective labelling of melittin with a fluorescent dansylcadaverine probe using guinea-pig liver transglutaminase

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Neoglycoproteins: in vitro introduction of glycosyl units at glutamines in beta-casein using transglutaminase.

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Site-specific modification of interleukin-2 by the combined use of genetic engineering techniques and transglutaminase

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Unique substrate specificities of two adjacent glutamine residues in EAQQIVM for transglutaminase: identification and characterization of the reaction products by electrospray ionization tandem mass spectrometry

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Transglutaminase-mediated dual and site-specific incorporation of poly(ethylene glycol) derivatives into a chimeric interleukin-2

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Interleukin-2: inception, impact, and implications

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Amino acid sequence of the factor XIIIa acceptor site in bovine plasma fibronectin

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Three-dimensional structure of interleukin-2

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Structure-activity studies of interleukin-2

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

High-level expression of human BSF-2/IL-6 cDNA in Escherichia coli using a new type of expression-preparation system

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Characterization of disulfide bonds in recombinant proteins: reduced human interleukin 2 in inclusion bodies and its oxidative refolding.

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Two adjacent N-terminal glutamines of BM-40 (osteonectin, SPARC) act as amine acceptor sites in transglutaminaseC-catalyzed modification.

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

A nonlinear least squares program based on differential equations, MULTI (RUNGE), for microcomputers.

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Further studies on the site-specific protein modification by microbial transglutaminase

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

X-ray analysis of glucagon and its relationship to receptor binding

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

The solution structure of the F42A mutant of human interleukin 2

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Unraveling the structure of IL-2

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

Phase I trial of 40-kd branched pegylated interferon alfa-2a for patients with advanced renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016/S0169-409X(02)50024-8

7 January 2021

10.1016/S0169-409X(02)00024-8

Identifiers

DOI

1 reference

3 August 2017

1 reference